, factor B (25) , factor D (26) , and properdin (P; 26) were purified to homogeneity, and C3 was trace-labeled with lesI (New England Nuclear) using iodogen (Pierce Chemical Corp., Rockford, Ill.; 27) to specific activities ranging from 7.2 × 104 cpm to 3.8 × l0 b cpm/#g without loss of functional activity. Veronal-buffered saline, pH 7.5, containing 0.1% gelatin (GVB), GVB mixed with an equal volume of 5% dextrose in water, and containing 0.5 mM MgCI2 and 0.15 mM CaC12 (DGVB ++) were used as diluents (28) .
The major cleavage fragment of C3, C3b-OR, that is bound to sheep E membrane constituents, was prepared by a two-step procedure (29) . 2 × 101° sheep E were incubated for o 125 30 min at 30 C with 5,600 #g C3, 80 #g I-C3, 1,200/.tg factor B, 10 pg factor D, and 10/zg P in 2 ml DGVB +÷ containing 5 mM MgCIe. The cells bearing C3b were washed five times with DGVB ÷+, and then incubated with 200 #g B, 10 #g D, and 10/~g P in 1 ml DGVB +÷ for 30 min at 30°C to form cellular intermediate-bearing P-stabilized amplification C3 convertase sites, C3b,Bb,P. These cells were centrifuged, resuspended in 1 ml cold DGVB ÷+ containing 600 #g levi-C3, incubated for 30 min at 30°C for the second stage of x25I-C3b deposition, and were washed three times with GVB. Solubilized membrane-bound t25I-C3b-OR was prepared by lysing 1 × 10 x° sheep E 125I-C3b in 5 ml of ice-cold 5 mM NaPO4, pH 6.9, containing 1 mg/ ml soybean trypsin inhibitor and 2 mg/ml lima bean trypsin inhibitor. The lysates were centrifuged at 149,000 g for 60 rain at 4°C in a Beckman ultracentrifuge, model L2-65B (Beckman Instruments Inc., Fullerton, Calif.), the pelleted membranes were resuspended in 5 ml of the same buffer and centrifuged again. The washed membranes were incubated for 30 min at 30°C in 4 ml veronal-buffered saline containing 0.25% Nonidet P-40 (BDH Chemical Ltd., Poole, England) and were then subjected to centrifugation at 149,000 g for 60 min at 4°C.
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The supernate-containing solubilized I-C3b-OR was concentrated fourfold by negative pressure filtration with a collodion bag (Schleicher and Schuell Inc., Keene, N. H.), and excess Nonidet P-40 was removed by adsorption with Bio-Beads SM-2 (Bio-Rad Laboratories). The preparations were sonicated for 5 s at a setting of 6 on a Branson Sonifier Cell Disrupter, model 350 (Branson Sonic Power Co., Danbury, Conn.), and were stored at -70°C. After thawing and before use in binding experiments, the preparations were again sonicated as above. Amounts of 125I-C3b-OR are expressed as #g of complement protein, disregarding the sheep E membrane constituents to which they are bound.
Binding Assays. PMN were isolated from citrated blood by dextran sedimentation of E and centrifugation of the leukocytes on Ficoll-Hypaque cushions (Pharmacia Fine Chemicals; 30). Residual E were hypotonically lysed and the PMN were washed in calcium-and magnesiumfree Hanks' balanced salt solution (Microbiological Associates, Walkersville, Md.) containing 2 mg bovine serum albumin (HBSS-BSA; Sigma Chemical Co.) per ml. Cell concentrations were determined with a model ZF Coulter Counter (Coulter Electronics, Hialeah, Fla.).
In standard antibody-binding assays, replicate samples of 5 × 106 PMN in 1 ml HBSS-BSA were preincubated for 20 min at 37°C with 100/xg of unlabeled nonimmune F(ab')2 and antiC3b receptor F(ab')2, respectively. 125I-F(ab')2 or x25I-Fah' anti-C3b receptor in 1 ml HBSS-BSA were then added to the replicate samples of cells and incubation continued for 20 min at 0 or 37°C. The PMN were washed three times with 2 ml of ice-cold HBSS-BSA and resuspended with 200/~g of 131I-IgG anti-F(ab')2 in 2 ml HBSS-BSA. After incubation for 1 h at 0°C, the cells were washed three times with ice-cold HBSS-BSA and assayed for bound x~I and xalI. Specific uptake of ~25I-F(ab')2 or ~25I-Fab' was calculated by subtracting the amount of these antibodies hound to cells that had been preincubated with immune F(ab')a from that bound to I 131 P cells preincubated with nonimmune F(ab )2. Specifically bound I-IgG anti-F(ab )2 was calculated by subtracting the ~3~I taken up by PMN previously incubated only with nonimmune F(ab')2 from that bound to cells that had been incubated also with 125I-F(ab')2 or 125I-Fab'.
Specific binding at equilibrium of l~I-C3b-OR to PMN was assayed by incubating replicate samples of 2.5 × 106 PMN in 0.08 ml HBSS-BSA for 30 min at 0°C with 10/~g of anti-C3b receptor F(ab')2 or nonimmune F(ab')2, followed by the addition of incremental amounts of x2SI-C3b-OR in 0.02 ml HBSS-BSA. After incubation for 45 min at 0 or 30°C, duplicate samples of 0.04 ml from each reaction mixture were layered on 0.3 ml of a mixture of 8 vol of dibutylphthalate and 2 vol of dinonylphthalate in polyethylene microfuge tubes (Brinkmann Instruments, Inc., Westbury, N. Y.). The tubes were centrifuged for 75 s at 8,000 g in a Beckman B microcentrifuge (Beckman Instruments Inc.) and cut just above the cell pellets, which were then assayed for ~25I.
Immunofluorescent Studies. For immunofluorescent studies, 5 × 105 PMN in 0.5 ml HBSS-BSA were incubated with 10 #g nonimmune F(ab')2, 10 #g anti-C3b receptor F(ab')2, 10 #g F(ab')2 anti-C3, and 20 #g anti-C3b receptor Fab', respectively, for 20 min at either 0 or 37°C. After the cells were washed twice with 2 ml ice-cold HBSS-BSA, they were resuspended with 0.5 ml HBSS-BSA containing 200 p.g TRITC-IgG anti-F(ab')2 that had been preadsorbed with 109 sheep E for 30 min at 0°C, and incubated at 0°C for 60 min. The PMN were washed twice with HBSS-BSA and were fixed by resuspension in 0.2 ml HBSS containing 2.5% paraformaldehyde and further incubation for 30 min at 0°C. The PMN were examined for fluorescence by placing a drop of cell suspensions on microscope slides, overlaying with coverslips, and observing at ×600 magnification with a Leitz fluorescence microscope (E. Leitz, Inc., Roekleigh, N. V.).
Results

Immunofluorescent Analysis of the Surface Distribution of C3b
Receptors on PMN.. PMN preincubated with nonimmune Fab' or F(ab')2 at 0 or at 37°C bound no detectable TRITC-IgG. PMN that had taken up anti-C3b receptor Fab' at 0°C demonstrated a punctate, clustered distribution of fluorescence that was most apparent when the focal plane was at the upper or lower surfaces of the cells (Fig. 1) ; only peripheral rims of patchy fluorescence were observed with the focal plane at the middle of cells (Fig. 1 ). An identical distribution of fluorescence was observed on PMN that had been treated with 2.5% paraformaldehyde at 0°C for 20 min before binding of Fab' anti-C3b receptor. To determine whether this distribution of C3b receptors was induced by prior uptake of C3b by PMN either in vivo or during collection of the Fro. 1. Fluorescent photomicrographs of PMN that had been sequentially incubated at 0°C with Fab' anti-C3b receptor and TRITC-IgG anti-F(ab')2. The plane of focus is at the top (left and middle panels) and at the middle of the cells (right panel).
PMN, cells were incubated with F(ab')2 anti-C3 at 0°C, washed, and incubated with T R I T C -I g G anti-F(ab')2. No immunofluorescence was observed on any PMN, suggesting that the clustered appearance of C3b receptors as demonstrated by anti-C3b receptor represented their native distribution.
PMN incubated with F(ab')2 at 0°C also demonstrated patchy fluorescence ( Fig.  2a and b) , whereas cells exposed to this bivalent ligand at 37°C had few fluorescence clusters, and some cells did not bind any detectable T R I T C -I g G anti-F(ab')2 ( Fig. 2e and f). A replicate sample of the PMN-bearing F(ab')2 anti-C3b receptor that had been taken up at 0°C was subsequently held at 37°C for 15 min, brought to 0°C, and was then incubated with T R I T C -I g G anti-F(ab')2 at 0°C. Fewer fluorescent clusters were visible on these cells ( Fig. 2c and d ) compared with the number present on the cells that were maintained at 0°C throughout the experiment ( Fig. 2a and b) . No capping of fluorescence was observed, although clusters on some PMN appeared to be distributed to one side of the cell. Thus, redistribution of the C3b receptor-F(ab')2 complexes formed at 0°C to a cellular compartment not accessible to the fluorescent second antibody occurred during incubation of the cells at 37°C.
Adsorptive Endocytosis of F(ab')z Anti-C3b
Receptor by PMN. The low uptake of T R I T C -I g G anti-F(ab')2 by PMN that had been incubated with F(ab')2 anti-C3b receptor at 37 rather than at 0°C could have been secondary to impaired binding of the primary antibody or to its internalization by the PMN, rendering it inaccessible Fic. 2. Light (a, c, and e) and corresponding fluorescent (b, d, and f) photomicrographs of PMN that had been sequentially incubated with F(ab')z anti-C3b receptor at 0°C, washed, and either held at that temperature (a and b) or incubated for 15 min at 37°C (c and d). PMN were also incubated for 20 min at 37"C with anti-C3b receptor (e and f). The PMN were then incubated with TRITC-IgG anti-F(ab')2. The plane of focus was at the top of the cells and magnification is × ~600.
to the secondary antibody. T o discriminate between these possible explanations, P M N that had been incubated with incremental amounts of 125I-F(ab')z anti-C3b receptor at 0 and at 37°C, respectively, were compared for their capacity to take up lSlI-IgG anti-F(ab')2 at 0°C. Binding of 125I-F(ab')z anti-C3b receptor to the cells was saturable at both temperatures, and a larger fraction of the input was taken up at 37 rather than at 0°C (Fig. 3) . T h e amounts of lalI-IgG anti-F(ab')2 that b o u n d to P M N previously incubated with anti-C3b receptor at 0°C were such that an approximate 2:1 molar ratio of IgG to F(ab')z occurred over the entire dose range of cell-bound F(ab')2 (Fig. 3) . P M N that had taken up comparable amounts of 125I-F(ab')2 anti-C3b receptor at 37°C had relatively diminished capacities to bind laXI-IgG anti-F(ab')2, and there was an inverse relationship between the n u m b e r of anti-C3b receptor molecules/PMN and the molar ratio of cell-associated IgG to F(ab')2 (Fig. 3) .
T o examine further the temperature dependence of the inaccessibility of P M Nb o u n d anti-C3b receptor, seven replicate samples of 5 × 106 P M N were each incubated for 20 rain at 0°C with 10 #g 125I-F(ab')2 anti-C3b receptor and washed at 0°C. Six samples were brought to 37°C by the addition of 0.5 ml of pre-warmed HBSS-BSA and one sample was held on ice in this buffer. At timed intervals during incubation at 37°C, individual samples of PMN were rapidly cooled by addition of 1.5 ml icecold HBSS-BSA, and held at 0°C. After 30 min, all samples of cells were centrifuged at 4°C, the supernatant fluids were removed, and the cells were assessed for their capacity to bind t31I-IgG anti-F(ab')2 at 0°C. PMN bearing 51,000 molecules of t2sI-F(ab')2 anti-C3b receptor/cell and held at 0°C throughout the experiment bound 94,000 molecules of x31I-IgG anti-F(ab')2/cell, yielding a 1.84:1 molar ratio of IgG to F(ab')2 (Fig. 4) , which is similar to that observed in the experiment depicted in Fig.  3 . PMN that were incubated at 37°C maintained their content of cell-associated antiC3b receptor but rapidly and progressively lost much of their capacity to take up anti-F(ab')2; the molar ratio of IgG to F(ab')2 had decreased to 0.57:1 with PMN that had been incubated at 37°C for 7.5 min (Fig. 4) .
The effect of the valency of the anti-C3b receptor on subsequent binding of anti-F(ab')2 by PMN was assessed by incubating cells for 20 min at 37°C with incremental concentrations of lZSI-F(ab')2 and 125I-Fab' anti-C3b receptor, respectively. The PMN were washed and incubated for 1 h at 0°C with 131I-IgG anti-F(ab')2 and assessed for cell-bound 1251 and 131I. Uptake of bivalent and monovalent anti-C3b receptor by PMN were saturable reactions, although an input of 2.5 times more t25I-Fab' was necessary to achieve binding that was equivalent to that observed with 125I-F(ab')z (Fig. 5) . The molar ratio of bound IgG to F(ab')2 decreased almost fivefold over the dose range of 10,000-42,000 molecules of anti-C3b receptor/PMN (Fig. 5) . However, binding of increasing amounts of morovalent anti-C3b receptor to PMN was not associated with impaired uptake of anti-F(ab')2 and the molar ratio of cell-bound to IgG to Fab' remained in the range of 2:1 over a dose range of 22,000-74,000 125I-Fab'/PMN (Fig. 5) .
The disparity in the accessibility to an extracellular ligand of PMN-bound monovalent and bivalent anti-C3b receptor was examined further by assessing the capacity of pronase to release these cell-associated antibody fragments. PMN were incubated at 37°C for 20 min with incremental concentrations of 125I-F(ab')2 and lZ~I-Fab' antiC3b receptor, respectively, and were washed and assayed for bound 125I. The PMN were then resuspended in 1 ml HBSS-BSA containing 500 ~g pronase/ml, incubated for an additional 15 min at 37°C and centrifuged, and the cell pellets were assayed for residual 125I. At the highest input of l~ZI-F(ab')2, 75,000 molecules were bound per PMN and 79% remained cell-associated after treatment with pronase (Fig. 6) . In contrast, only 17% of the 94,000 12SI-Fab' molecules/PMN that were bound at the highest input of the monovalent anti-C3b receptor remained cell-associated after treatment of the cells with pronase (Fig. 6) .
To assess the involvement of cytochalasin B-sensitive cytoskeletal elements in C3b receptor-mediated endocytosis, 5 × 106 PMN were incubated for 10 min at 37°C in 0.5 ml HBSS-BSA containing 5 #g eytochalasin B/ml and 0.5% dimethyl sulfoxide (DMSO), and a replicate sample of PMN was incubated with buffer containing only DMSO. 4 ~g of 125I-F(ab')2 anti-C3b receptor was added to each reaction mixture and incubation was continued for 20 min at 37°C, after which the cells were washed 
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Fro. 7. Binding of incremental inputs t25I-C3b-OR to PMN at O°C (') and at 30°C (Q) in the presence of non-immune F(ab')2 (solid lines) or anti-C3b receptor F(ab')2 (dashed lines).
and assessed for their capacity to bind 13Xl-IgG anti-F(ab)~ at 0°C. PMN preincubated with buffer containing only DMSO and bearing 51,000 F(ab')2 molecules/cell subsequently bound 31,280 IgG molecules/ceil, representing a 0.61:1 molar ratio of IgG to F(ab')2. PMN that had taken up 45,300 molecules/cell of anti-C3b receptor in the presence of cytochalasin B bound 27,640 molecules/cell of anti-F(ab')2, yielding an identical 0.61:1 molar ratio of IgG to F(ab')2.
Adsorptive Endocytosis of l~l-C3b-OR by PMN. Incremental amounts of 12~I-C3b-OR
that had been solubilized from sheep E membranes to which the complement protein had affixed were incubated at 0 or at 30°C for 45 min with PMN in the presence of nonimmune or anti-C3b receptor F(ab')2. Uptake of 125I-C3b-OR by the cells in the presence of nonimmune F(ab')2 was slightly greater at 37 than at 0°C, and the binding curves were concave to the abscissa throughout the analyses, indicating saturable reactions (Fig. 7) . In contrast, the binding of 12~I-C3b-OR to PMN was greatly diminished by the presence of anti-C3b receptor, was a linear function of the input of the ligand, and thus, was nonsaturable or nonspecific (Fig. 7) . Internalization of 1251-C3b-OR by PMN was assessed by incubating 5 X 106 PMN in 1 ml HBSS-BSA with incremental amounts of the ligand for 20 min at 37°C. The cells were washed twice with 2 ml HBSS-BSA and were assayed for bound 125I-C3b-OR. The cells were then suspended in 1 ml HBSS-BSA containing 500 #g pronase and incubation was continued for 15 min at 37°C. After centrifugation and removal of the supernatant fluids, the cell pellets were assayed for residual-associated t25I-C3b-OR. Greater than 90% of the radioactivity initially bound by the PMN at each input of the ligand was susceptible to release by pronase, indicating that the C3b receptorligand complex had remained at the cell surface (Fig. 8) .
Because bivalent, but not monovalent, anti-C3b receptor was internalized by C3b receptors, the effect of cross-linking l~SI-C3b-OR bound by PMN on the endocytosis of this ligand was examined. Replicate samples of 5 × 106 PMN in 1 ml HBSS-BSA were each incubated for 45 min at 0°C with 0.27 #g 12aI-C3b-OR, and the cells were washed twice with ice-cold buffer and resuspended in 1 ml HBSS-BSA alone or containing incremental concentrations of Fab' or F(ab')2 anti-C3. After incubation for 20 rain at 37°C, the PMN were washed twice at 0°C and assayed for cell-bound 125I. The cells were then resuspended in 1 ml HBSS-BSA containing 500 gg pronase, incubated for 15 min at 37°C, centrifuged, and assayed for residual-associated 125I after removal of the supernatant fluids. Incubation of PMN-bearing 125I-C3b-OR with monovalent or bivalent anti-C3 did not alter the amount of cell-bound radiolabeled ligand before treatment with pronase (Fig. 9) . Fab' anti-C3 had only a minimal effect on the percentage of x25I-C3b-OR removed from the PMN by pronase, which was 91 and 85% with PMN that had been incubated with buffer and with the highest input of monovalent anti-C3, respectively. In contrast, F(ab')2 anti-C3 induced a dose-related increase in the amount of x25I-C3b-OR remaining cell-associated after pronase treatment, so that only 20-30% of the ligand was released by proteolytic treatment of cells that had been exposed to the highest concentrations of the bivalent anti-C3 (Fig. 9) . Discussion The capacity of C3b receptors on PMN to mediate internalization at 37°C of 1251-F(ab')z anti-C3b receptor was established by the relative inaccessibility of ligand taken up at 37°C to two extracellular probes, IgG anti-F(ab')2 and pronase. The F(ab')2 fragments were separated from residual intact IgG by gel filtration and adsorption with Sepharose-protein A, and no intact heavy chains were seen on polyacrylamide gel electrophoresis; thus, internalization of the antibody by Fc receptors was excluded. The clusters of C3b receptors that were observed by indirect immunofluorescence of PMN that had been bound anti-C3b receptor at 0°C were almost absent on cells that had been incubated with the antibody at 37°C, which suggests that endocytosis of the antibody had occurred at the higher temperature (Fig.  2) . This possibility was confirmed and quantitated in dose-response experiments measuring the sequential uptake by PMN of 125I-F(ab')2 anti-C3b at 0 and 37°C, respectively, and of 131I-IGG anti-F(ab')2 at 0°C. Each molecule of anti-C3b receptor bound by PMN at 0°C subsequently took up an average two molecules ofanti-F(ab')2 over the entire dose-range of cell-associated 125I-F(ab')z, establishing a 2:1 molar ratio of cell-bound IgG to F(ab')2 under conditions that excluded receptor-mediated endocytosis. In contrast, when increments of anti-C3b receptor were taken up by PMN at 37°C, there was a progressive decline in the capacity of the cell-associated antibody to bind IgG anti-F(ab')2. A cell-bound molar ratio of only 0.2 IgG molecules/ F(ab')z occurred with PMN that had taken up the highest number of anti-C3b receptor molecules at 37°C and this is taken to indicate that 90% of the ligand bound to C3b receptors had been endocytosed. Anti-C3b receptor bound to PMN at 0°C rapidly became inaccessible to the second antibody during incubation of the cells at 37°C, with a half-time for internalization of <5 min (Fig. 4) , indicating that endocytosis was stimulated by the ligand, rather than being secondary to normal metabolic turnover of the receptor.
The increasing proportion of F(ab')2 anti-C3b receptor that was rendered inaccessible to anti-F(ab')2 when larger amounts of the primary antibody were taken up by PMN at 37°C (Fig. 3) suggested that muhivalent interaction of this ligand with the receptor was required to stimulate internalization. Incubation of PMN with incremental amounts of monovalent 125I-Fab' anti-C3b receptor at 37°C was not associated with impaired subsequent uptake of 131I-IgG anti-F(ab')z as a relatively constant molar ratio of two IgG bound/Fab' was observed (Fig. 5) . Moreover, treatment with pronase of PMN-bearing 12~I-Fab' anti-C3b receptor that had been taken up at 37°C removed >80% of the cell-bound 1251, whereas, in a parallel experiment, pronase treatment of PMN that had bound 76,000 125I-F(ab')z anti-C3b receptor molecules/ cell released only 25% of the cell-associated 125I (Fig. 6 ). Thus, cross-linking of C3b receptors by ligand appears to be necessary for the pinocytotic reaction.
The capacity of C3b receptors on PMN to mediate internalization of the bivalent antibody fragment prompted an examination of their interaction with the natural ligand, C3b. This cleavage fragment of C3 may be present in its free form, C3b, in which a carbonyl that is derived from an internal thioester (31) has reacted with H20, or in a state designated as C3b-OR, in which the carbonyl has formed an ester linkage to constituents of the immune complex bearing the C3 convertase (1). C3b-OR, rather than free C3b, was used in these studies because 15-80% of the former has been shown to be capable of binding to C3b receptors on human erythrocytes, whereas <1% of the latter had this activity. 2 125I-C3b-OR was bound by PMN in a saturable reaction that was abolished by preincubation of the cells with anti-C3b receptor F(ab')2, indicating that both ligands interacted with the same cell surface structure (Fig. 7) . Because treatment with pronase of PMN bearing incremental amounts of 12SI-C3b-OR that had been taken up during incubation at 37°C released >90% of the cell-associated 125I, this monovalent receptor-ligand complex was not internalized (Fig. 8) . Cross-linking of the bound a25I-C3b-OR by introducing increasing amounts of F(ab')2 anti-C3 to create muhivalent ligands, however, induced a dose-related increase in the amount of the complement protein that was inaccessible to proteolytic stripping (Fig. 9) . Thus, the natural ligand for C3b receptors on PMN elicited an endocytotic response when presented as a muhivalent structure, as had antibody to the receptor.
The C3b receptor of PMN has been considered to participate only in the attachment phase of endocytosis because these cells bind, but do not internalize, sheep E bearing C3b (9, 10); phagocytosis occurs only when targets also carry IgG, which permits their interaction with Fc receptors on PMN. However, the finding that PMN internalized F(ab')2 anti-C3b receptor and C3b-OR that had been cross-linked with anti-C3, indicates that C3b receptors are capable of mediating internalization of soluble, rather than particulate, ligand by adsorptive pinocytosis. A distinction between these two types of endocytotic reactions could reside in the cytoskeletal elements that are involved, because cytochalasin B, which impairs phagocytosis (32), had no inhibitory effects on internalization of F(ab')2 anti-C3b receptor, which suggests that the latter reaction is not mediated by microfilaments. A cytoplasmic structural protein possibly involved in C3b receptor-mediated endocytosis is clathrin, because endocytotic receptors on other cell types accumulate in clathrin-coated pits (20, 33) , which yield a clustered distribution of receptors similar to that observed for the C3b receptor ( Figs. 1 and 2) . Regardless of the mechanism, the demonstration of this functional capacity for C3b receptors indicates that they can directly mediate the clearance of C3b-bearing soluble complexes. Summary C3b receptors on human polymorphonuclear leukocytes (PMN) were nonrandomly distributed in small clusters on the plasma membranes of these cells when assessed by indirect immunofluorescence at 0°C using monospecific rabbit Fab' or F(ab')2 antiC3b receptor and tetramethylrhodamine isothiocyanate (TRITC)-conjugated goat IgG anti-F(ab')2. When PMN were incubated with the bivalent anti-C3b receptor at 37 rather than at 0°C, almost no immunofiuorescence was observed, which indicates that the C3b receptor-F(ab')2 complexes had been rendered inaccessible to TRITCIgG anti-F(ab')2. Endocytosis of the anti-C3b receptor ligand was quantitated by measuring the binding 131I-IgG anti-F(ab')z by PMN that had previously taken up azSI-F(ab')z anti-C3b receptor at 0 and at 37°C, respectively. There was a constant 2: 1 molar ratio of anti-F(ab')2 to anti-C3b receptor with PMN that had been incubated with the first antibody at 0°C. In contrast, when increments of F(ab')2 anti-C3b receptor were taken up by the cells at 37°C, there was a dose-related decline in this molar ratio to a minimum of 0.2 molecules of anti-F(ab')z bound per molecule of PMN-associated anti-C3b receptor. 12SI-F(ab')2 anti-C3b receptor taken up by PMN at 37°C was also inaccessible to release by proteolytic treatment of the cells with pronase. The rate of endocytosis of lzSI-F(ab')2 anti-C3b receptor was rapid as the PMN-bound antibody fragment became inaccessible to 131I-IgG anti-F(ab')2 within 10 min during incubation of the cells at 37°C. In contrast to these findings, 125I-Fab' anti-C3b receptor that was taken up by PMN at 37°C remained accessible to both 181I-IgG anti-F(ab')2 and to proteolytic release by pronase, which suggests that monovalent interaction of ligand with C3b receptors was not sufficient for induction of endocytosis. The requirement for multivalency was also demonstrated using the C3b-OR, the normal ligand for the C3b receptor. 125I-C3b-OR was specifically bound by PMN but remained on the cell surface, as determined by its accessibility to pronase, unless it was cross-linked with F(ab')2 anti-C3. Although C3b receptors on PMN do not mediate internalization of particulate ligand, their newly recognized capacity to function in receptor-mediated adsorptive pinocytosis of soluble ligand indicates their potential for the clearance of C3b-bearing immune complexes without recruitment of other cell surface receptors.
